WASHINGTON — Donald Trump is unorthodox, to say the least, when it comes to his opinions about the drug industry.
The GOP has historically been a staunch ally for drug companies. But during and after the campaign, the Republican president-elect has sworn he would bring down drug costs, flirting with policies that sound more in line with Bernie Sanders than Paul Ryan.
I don’t agree. Read that
http://www.nytimes.com/2011/09/27/opinion/to-save-on-health-care-first-crack-down-on-fraud.html